Parrot L, Dong C, Carbonnel F, Meyer A, et al. Systematic review with meta-analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor. Aliment Pharmacol Ther 2022;55:380-388.
PMID: 34854100